Angiogenesis: What's the alternative?

Nature Reviews Cancer

Volumn 12, Issue 2, 2012, Pages 80-81

  Seton Rogers, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SERINE RICH SPLICING FACTOR 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN B;

CYTOPLASM; DENYS DRASH SYNDROME; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IN VIVO STUDY; NEPHROBLASTOMA; NONHUMAN; NOTE; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SUBRETINAL NEOVASCULARIZATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 84856228958     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3207     Document Type: Note

References (1)

1. Amin, E. A. et. al. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 20, 768-780 (2011)